0001193125-20-186952.txt : 20200702 0001193125-20-186952.hdr.sgml : 20200702 20200702171542 ACCESSION NUMBER: 0001193125-20-186952 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200630 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 201010800 BUSINESS ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 8-K 1 d936503d8k.htm FORM 8-K Form 8-K
false 0001623613 0001623613 2020-06-30 2020-06-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2020

 

MYLAN N.V.

(Exact name of registrant as specified in its charter)

 

Netherlands

 

333-199861

 

98-1493528

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

Building 4, Trident Place,

Mosquito Way, Hatfield, Hertfordshire, AL10 9UL, England

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: +44 (0) 1707-853-000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Ordinary shares, nominal value 0.01

 

MYL

 

The NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) On June 30, 2020, Mylan N.V. (“Mylan” or the “Company”) held its annual general meeting of shareholders (the “AGM”) to (i) appoint two executive directors and eleven non-executive directors, each for a term ending immediately after the next annual general meeting held after their appointment; (ii) approve, on an advisory basis, the compensation of the named executive officers of the Company; (iii) adopt the Dutch annual accounts for fiscal year 2019; (iv) ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2020; (v) instruct Deloitte Accountants B.V. for the audit of the Company’s Dutch statutory annual accounts for fiscal year 2020; (vi) authorize Mylan’s Board of Directors (the “Mylan Board”) to acquire shares in the capital of the Company; and (vii) delegate to the Mylan Board the authority to issue ordinary shares and grant rights to subscribe for ordinary shares in the capital of the Company and to exclude or restrict pre-emptive rights.

On June 30, 2020, Mylan also held its extraordinary general meeting of shareholders (the “EGM”) in connection with the proposed transaction pursuant to which Mylan will combine with Pfizer Inc.’s (“Pfizer”) Upjohn business (the “Upjohn Business”) in a Reverse Morris Trust transaction (the “Combination”) to (i) approve the Combination Proposal (as defined below); (ii) adopt the Compensation Proposal (as defined below); (iii) adopt the Proposal Regarding Procedures for Determining Board Composition (as defined below); and (iv) adopt the Stockholder Special Meetings Proposal (as defined below).

As of the close of business on June 2, 2020, the record date for both the AGM and the EGM (the “Record Date”), there were issued and outstanding 516,947,234 ordinary shares of Mylan entitled to vote at each of the AGM and the EGM. As of the Record Date, there were no preferred shares of Mylan issued and outstanding. At least 50% of Mylan’s issued share capital was present or represented at each of the AGM and the EGM with respect to each proposal below, which exceeds the required quorum of at least one-third of Mylan’s issued share capital present or represented for each such proposal. With respect to each proposal below, any abstentions, “blank votes” and invalid votes were counted for the purposes of determining the presence of a quorum, but were not considered to be votes cast and therefore had no effect on the vote on any such proposal. Any “broker non-votes” with respect to any proposal were not treated as shares present for purposes of determining the presence of a quorum with respect to such proposal and were not considered to be votes cast and therefore had no effect on the vote on such proposal.

(b) The certified results of the matters voted on at the AGM are set forth below.

Proposal No. 1 - Appointment of two executive directors and eleven non-executive directors, each for a term ending immediately after the next annual general meeting held after their appointment:

Nominee

 

For

   

Against

   

Abstain

   

Broker Non-

Votes

 

Heather Bresch*

   

392,020,138

     

5,690,162

     

6,160,809

     

28,894,148

 

Hon. Robert J. Cindrich

   

393,818,255

     

3,805,275

     

6,247,578

     

28,894,149

 

Robert J. Coury

   

392,922,513

     

10,388,372

     

560,226

     

28,894,146

 

JoEllen Lyons Dillon

   

331,195,916

     

66,371,847

     

6,303,346

     

28,894,148

 

Neil Dimick, C.P.A.

   

388,392,842

     

9,156,326

     

6,321,939

     

28,894,150

 

Melina Higgins

   

340,711,749

     

56,851,069

     

6,308,292

     

28,894,147

 

Harry A. Korman

   

393,987,947

     

3,609,971

     

6,273,191

     

28,894,148

 

Rajiv Malik*

   

389,141,791

     

8,514,820

     

6,214,500

     

28,894,146

 

Richard Mark, C.P.A.

   

394,841,624

     

2,761,789

     

6,267,697

     

28,894,147

 

Mark W. Parrish

   

398,985,037

     

4,383,559

     

502,513

     

28,894,148

 

Pauline van der Meer Mohr

   

347,353,949

     

55,892,112

     

625,046

     

28,894,150

 

Randall L. (Pete) Vanderveen, Ph.D.

   

398,071,372

     

5,169,409

     

630,328

     

28,894,148

 

Sjoerd S. Vollebregt

   

394,919,606

     

2,666,875

     

6,284,627

     

28,894,149

 

* Refers to an executive director. All other directors listed above are non-executive directors.


Consistent with established Dutch law and Mylan’s Articles of Association, each director nominee was appointed by the AGM.

Proposal No. 2 – Approval, on an advisory basis, of the compensation of the named executive officers of the Company:

For

 

Against

 

Abstain

 

Broker Non-Votes

225,411,931

 

177,536,054

 

923,120

 

28,894,152

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

Proposal No. 3 – Adoption of the Dutch annual accounts for fiscal year 2019:

For

 

Against

 

Abstain

 

Broker Non-Votes

429,338,535

 

2,173,828

 

2,184,534

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

Proposal No. 4 – Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2020:

For

 

Against

 

Abstain

 

Broker Non-Votes

418,014,827

 

15,111,073

 

570,992

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

Proposal No. 5 – Instruction to Deloitte Accountants B.V. for the audit of the Company’s Dutch statutory annual accounts for fiscal year 2020:

For

 

Against

 

Abstain

 

Broker Non-Votes

418,092,028

 

14,925,803

 

679,059

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

Proposal No. 6 – Authorization of the Mylan Board to acquire shares in the capital of the Company:

For

 

Against

 

Abstain

 

Broker Non-Votes

428,590,107

 

3,548,890

 

1,557,893

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.


Proposal No. 7 – Delegation to the Mylan Board of the authority to issue ordinary shares and grant rights to subscribe for ordinary shares in the capital of the Company and to exclude or restrict pre-emptive rights:

For

 

Against

 

Abstain

 

Broker Non-Votes

427,253,142

 

4,646,461

 

865,654

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

(c) The certified results of the matters voted on at the EGM are set forth below.

Proposal No. 1 – Approval of the following matters relating to the Combination (collectively, the “Combination Proposal”):

  Approval of the Mylan Merger: Resolution to enter into and effectuate a legal triangular merger (juridische driehoeksfusie), whereby Mylan, as disappearing company, will merge with and into Mylan II B.V. (“Mylan Newco Sub”), as acquiring company, and whereby Mylan I B.V. (“Mylan Newco”) will allot shares in its capital to Mylan shareholders at the time of such merger in accordance with the merger proposal that will be deposited with the Dutch trade registry and disclosed for public inspection, prepared by the respective boards of directors of Mylan, Mylan Newco and Mylan Newco Sub (the “Mylan Merger”);

  Approval of the Share Sale: Resolution to approve, under Section 2:107a of the Dutch Civil Code, the sale and transfer by Mylan Newco, immediately following the time at which the Mylan Merger becomes effective (the “Mylan Merger Effective Time”), of all issued and outstanding shares in the capital of Mylan Newco Sub to Utah Acquisition Sub Inc. (“Acquisition Sub”) or its designated nominee (the “Share Sale”);

  Approval of the Mylan Newco Liquidation: Resolution to, effective as of the time at which the Share Sale becomes effective, approve and effectuate (i) the dissolution of Mylan Newco (ontbinding) and its subsequent liquidation (vereffening) in accordance with Sections 2:19 and 2:23b of the Dutch Civil Code, (ii) the appointment of Stichting Liquidator Mylan (the “Liquidator”) as liquidator (vereffenaar) of Mylan Newco and (iii) the appointment of an affiliate of Upjohn Inc. (the “Liquidation Custodian”) as custodian of the books and records of Mylan Newco in accordance with Section 2:24 of the Dutch Civil Code;

  Approval of the Alternative Transaction Structure: Resolution to, if the Mylan Merger is not consummated within the period specified by Section 2:318(1) of the Dutch Civil Code, (i) approve, under Section 2:107a of the Dutch Civil Code, the sale, transfer, assignment and delivery by Mylan to Acquisition Sub or its designated nominee of all of the right, title and interest of Mylan in, to and under all of its assets (the “Asset Sale”), and (ii) approve and effectuate, as soon as practicable following the Asset Sale, (x) the dissolution of Mylan (ontbinding) and its subsequent liquidation (vereffening) in accordance with Sections 2:19 and 2:23b of the Dutch Civil Code, (y) the appointment of the Liquidator as liquidator (vereffenaar) of Mylan and (z) the appointment of the Liquidation Custodian as custodian of the books and records of Mylan in accordance with Section 2:24 of the Dutch Civil Code; and

  Approval of the Discharge of Directors: Resolution to, effective upon the Mylan Merger Effective Time or the effective time of the Asset Sale (which shall be 6:00 p.m., New York City time, on the date of the Asset Sale), as applicable, provide full and final discharge to each member of the Mylan Board for their acts of management or supervision, as applicable, up to the date of the EGM; provided that no discharge shall be given to any director for acts as a result of fraud (bedrog), gross negligence (grove schuld) or willful misconduct (opzet) of such director:

For

 

Against

 

Abstain

 

Broker Non-Votes

401,554,656

 

1,656,652

 

661,168

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.


Proposal No. 2 – Adoption of a non-binding, advisory resolution to adopt the golden parachute compensation that will or may be paid or become payable to those named executive officers of Mylan who depart from the Company in connection with, or following, the consummation of the Combination (the “Compensation Proposal”):

For

 

Against

 

Abstain

 

Broker Non-Votes

131,650,119

 

271,521,572

 

700,783

 

0

The proposal did not receive the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore did not pass.

Proposal No. 3 – Adoption of a non-binding, advisory resolution to adopt certain features of Upjohn Inc.’s (“Newco”) governance which will replace the corresponding features of Mylan’s governance, effective upon the closing of the Combination, relating to (i) the right of stockholders to nominate directors and make other stockholder proposals at stockholder meetings and (ii) director terms and stockholder removal of directors (the “Proposal Regarding Procedures for Determining Board Composition”):

For

 

Against

 

Abstain

 

Broker Non-Votes

398,831,423

 

4,142,917

 

898,136

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

Proposal No. 4 – Adoption of a non-binding, advisory resolution to adopt certain features of Newco’s governance which will replace the corresponding features of Mylan’s governance, effective upon the closing of the Combination, relating to the right of stockholders to call special meetings of stockholders (the “Stockholder Special Meetings Proposal”):

For

 

Against

 

Abstain

 

Broker Non-Votes

369,446,363

 

33,500,004

 

926,110

 

0

The proposal received the affirmative vote of a majority of the votes cast by shareholders entitled to vote and therefore passed.

Additional Information and Where to Find It

This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. In connection with the proposed combination of Newco and Mylan, which will immediately follow the proposed separation of the Upjohn Business from Pfizer (the “proposed transaction”), Newco and Mylan have filed certain materials with the Securities and Exchange Commission (“SEC”), including, among other materials, the Registration Statement on Form S-4, as amended, which includes a proxy statement/prospectus (as amended, the “Form S-4”), which was filed by Newco with the SEC on October 25, 2019 and declared effective by the SEC on February 13, 2020, the Registration Statement on Form 10, which includes an information statement (the “Form 10”), which was filed by Newco with the SEC on June 12, 2020 and declared effective by the SEC on June 30, 2020, a definitive proxy statement, which was filed by Mylan with the SEC on February 13, 2020 (the “EGM Proxy Statement”), and a prospectus, which was filed by Newco with the SEC on February 13, 2020 (the “Prospectus”). The EGM Proxy Statement and the Prospectus were first mailed to shareholders of Mylan on or about February 14, 2020 to seek approval of the proposed transaction. Newco and Mylan intend to file additional relevant materials with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT MYLAN, NEWCO AND THE PROPOSED TRANSACTION. The documents relating to the proposed transaction (when they are available) can be obtained free of charge from the SEC’s website at www.sec.gov. These documents (when they are available) can also be obtained free of charge from Mylan, upon written request to Mylan or by contacting Mylan at (724) 514-1813 or investor.relations@mylan.com or from Pfizer on Pfizer’s internet website at https://investors.Pfizer.com/financials/sec-filings/default.aspx or by contacting Pfizer’s Investor Relations Department at (212) 733-2323, as applicable.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

MYLAN N.V.

             

Date: July 2, 2020

 

 

By:

 

/s/ Kenneth S. Parks

 

 

 

Kenneth S. Parks

 

 

 

Chief Financial Officer

EX-101.SCH 2 myl-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 myl-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Region Entity Address, Region Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 myl-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 d936503d8k_htm.xml IDEA: XBRL DOCUMENT 0001623613 2020-06-30 2020-06-30 false 0001623613 8-K 2020-06-30 MYLAN N.V. P7 333-199861 98-1493528 Building 4 Trident Place Mosquito Way Hatfield Hertfordshire AL10 9UL GB 44 (0) 1707-853-000 true false false false Ordinary shares, nominal value €0.01 MYL NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information
Jun. 30, 2020
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001623613
Document Type 8-K
Document Period End Date Jun. 30, 2020
Entity Registrant Name MYLAN N.V.
Entity Incorporation State Country Code P7
Entity File Number 333-199861
Entity Tax Identification Number 98-1493528
Entity Address, Address Line One Building 4
Entity Address, Address Line Two Trident Place
Entity Address, Address Line Three Mosquito Way
Entity Address, City or Town Hatfield
Entity Address, Region Hertfordshire
Entity Address, Postal Zip Code AL10 9UL
Entity Address, Country GB
City Area Code 44 (0)
Local Phone Number 1707-853-000
Written Communications true
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Ordinary shares, nominal value €0.01
Trading Symbol MYL
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d936503d8k.htm myl-20200630.xsd myl-20200630_lab.xml myl-20200630_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d936503d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d936503d8k.htm" ] }, "labelLink": { "local": [ "myl-20200630_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "myl-20200630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "myl-20200630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "myl", "nsuri": "http://www.mylan.com/20200630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d936503d8k.htm", "contextRef": "duration_2020-06-30_to_2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d936503d8k.htm", "contextRef": "duration_2020-06-30_to_2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the region.", "label": "Entity Address, Region", "terseLabel": "Entity Address, Region" } } }, "localname": "EntityAddressRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mylan.com//20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001193125-20-186952-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-186952-xbrl.zip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end